880
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Limited-stage mantle cell lymphoma: not so different from advanced-stage

&
Pages 217-218 | Published online: 16 Oct 2012

References

  • Ghielmini M, Zucca E. How I treat mantle cell lymphoma. Blood 2009;114:1469–1476.
  • Straus DJ. How I treat mantle cell lymphoma. J Oncol Pract 2007;3:281–282.
  • Bernard M, Tsang RW, Le LW, . Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital. Leuk Lymphoma 2012;53:XXX–XXX.
  • Rosenbluth BD, Yahalom J. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT). Int J Radiat Oncol Biol Phys 2006;65: 1185–1191
  • Leitch HA, Gascoyne RD, Chhanabhai M, . Limited-stage mantle-cell lymphoma. Ann Oncol 2003;14:1555–1561.
  • Chandran R, Gardiner SK, Simon M, . Survival trends in mantle cell lymphoma in the United States over 16 years 1992–2007. Leuk Lymphoma 2012;53:1488–1493.
  • Zhou Y, Wang H, Fang W, . Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer 2008;113:791–798.
  • Romaguera JE, Medeiros LJ, Hagemeister FB, . Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer 2003;97:586–591.
  • Salar A, Juanpere N, Bellosillo B, . Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol 2006;30:1274–1280.
  • Brepoels L, Stroobants S, De Wever W, . Positron emission tomography in mantle cell lymphoma. Leuk Lymphoma 2008;49: 1693–1701.
  • Hosein PJ, Pastorini VH, Paes FM, . Utility of positron emission tomography scans in mantle cell lymphoma. Am J Hematol 2011;86:841–845.
  • Tsukamoto N, Kojima M, Hasegawa M, . The usefulness of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and a comparison of 18F-FDG-pet with 67gallium scintigraphy in the evaluation of lymphoma. Cancer 2007;110: 652–659.
  • Elstrom R, Guan L, Baker G, . Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003;101:3875–3876.
  • Martin P, Chadburn A, Christos P, . Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding seven years in a large cohort of patients managed primarily with conservative therapies. Blood 2007;110(Suppl. 1): Abstract 1362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.